Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
p16 a biomarker of aging and tolerance for cancer therapy
Hyman B. Muss
*
, Andrew Smitherman
, William A. Wood
, Kirsten Nyrop
, Sascha Tuchman
, Paramjeet K. Randhawa
, Amy R. Entwistle
, Natalia Mitin
,
Shlomit S. Shachar
*
Corresponding author for this work
University of North Carolina at Chapel Hill
Sapere Bio
Technion-Israel Institute of Technology
Research output
:
Contribution to journal
›
Review article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'p16 a biomarker of aging and tolerance for cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Patients
100%
Cancer Therapy
100%
Physiological Aging
100%
Aging Biomarkers
100%
P16 Expression
66%
Chemotherapy
33%
Health Status
33%
Middle-aged
33%
In Cancer
33%
Older Patients
33%
P16INK4a
33%
Murine Model
33%
Hereafter
33%
Middle-aged Patients
33%
Life Expectancy
33%
Overall Survival
33%
Young Patients
33%
Chronological Age
33%
Patients with Cancer
33%
Clinical Utility
33%
Environmental Stressors
33%
Functional Domain
33%
Physical Domain
33%
Cognitive Domains
33%
Cell Senescence
33%
Physiological Age
33%
Cellular Senescence
33%
Health Deficits
33%
Supportive Cancer Care
33%
Biochemistry, Genetics and Molecular Biology
P16
100%
Health Status
12%
Life Expectancy
12%
Overall Survival
12%